Favorable Price Nootropic Powder Vinpocetine CAS 42971-09-5 with Safe Delivery
Price | USD10.00 | USD15.00 | USD20.00 |
Packge | 1kg | 1kg | 1kg |
- Min. Order:1kg
- Supply Ability:1ton/Month
- Time:2022-07-05
Product Details
- Product NameVinpocetine
- CAS No.42971-09-5
- EINECS No.256-028-0
- MFC22H26N2O2
- MW350.46
- Appearancesolidwhite
- Melting point 147-153 °C dec.
- storage temp. Sealed in dry,2-8°C
- Boiling point 484.44°C (rough estimate)
- density 1.1260 (rough estimate)
Basic Info.
Product Description
Favorable Price Nootropic Powder Vinpocetine CAS 42971-09-5 with Safe Delivery
Product Name: Vinpocetine;
Synonyms:
3A,16A-APOVINCAMINIC ACID ETHYL ESTER;(3A,16A)-EBURNAMENINE-14-CARBOXYLIC ACID ETHYL ESTER;CAVINTON;ETHYL APOVINCAMIN-22-OATE;EBURNAMENINE;EBURNAMENINE-14-CARBOXYLIC ACID ETHYL ESTER;RGH-4405;VINPOCETIN;
CAS: 42971-09-5;
EINECS: 256-028-0
MF: C22H26N2O2;
MW: 350.45.
Product name: | Vinpocetine |
Other Name: | 3A,16A-APOVINCAMINIC ACID ETHYL ESTER;(3A,16A)-EBURNAMENINE-14-CARBOXYLIC ACID ETHYL ESTER;CAVINTON;ETHYL APOVINCAMIN-22-OATE; EBURNAMENINE; EBURNAMENINE-14-CARBOXYLIC ACID ETHYL ESTER;RGH-4405;VINPOCETIN; |
Original: | China |
CAS: | 42971-09-5 |
EINECS | 256-028-0 |
Molecular formula: | C22H26N2O2 |
MW: | 350.45 |
Brand name | LINWO |
Leading time | within 24 hours upon receipt of payment |
Delivery | Fast and secure shipping by EMS, DHL, TNT, FedEx, UPS |
Purity | 99% |
Package | Discreet and Hidden package according to specific requirement |
Appearance | White crystal powder |
Certification | SGS, ISO 9001, KOSHER |
Medicinal properties and Application:
(1) Vinpocetine is a kind of natural medicine extracted from small vinca flower, and belongs to the indole alkaloids. Can be synthetic now. The mechanism of its pharmacological action is to inhibit the activity of calcium dependency phosphodiesterase, increase the content of CGMP which can relax vascular smooth muscle, then relax vascular smooth muscle, and further increase cerebral blood flow; Enhance the capacity of deformation of red blood cells, reduce blood viscosity, inhibit platelet aggregation, and thus improve blood flow and microcirculation;
(2) Promote the brain tissue to absorb glucose, and promote the transformation of brain monoamine metabolism; Inhibit the increase of brain lactic acid during cerebral ischemia, increase the ATP content, increase thedegree of oxygen dissociation in hemoglobin; Increase the resistance capacity for cerebral anoxia and occurring of spasm caused by cerebral ischemia, inhibit the generation of lipid peroxide in the brain.
(3) Oral absorption effectively, reach peak at 1 h, then metabolize into Vinpocetine in the body. The half-life of plasma elimination is about 1 hour. For 4 weeks in a row, no accumulation in the body.
(4) Clinical used in cerebral infarction sequela, cerebral hemorrhage sequelae, cerebral arteriosclerosis, cerebral vasospasm, brain endarteritis caused vertigo, tinnitus, headache, dizziness, limb numbness, incontinence and other clinical manifestations, depression, anxiety, sleep disorder and other mental symptoms. Clinical experience has shown that it is effective regardless of the length of the course of the disease, and the symptom is fixed or not.
Company Profile Introduction
Recommended supplier
-
VIP1年
- Chemical Resources
- 42971-09-5 / 80038-06-8 Vinpocetine 99%
- Inquiry
- 2024-03-07
-
VIP1年
- Quad Lifesciences Pvt Ltd
- Vinpocetine 42971-09-5 / 80038-06-8 99%
- Inquiry
- 2024-03-01
-
VIP1年
- Ennature Biopharma (A Division of India Glycols Limited)
- Vinpocetine 98%
- Inquiry
- 2024-03-01
-
VIP1年
- Ralington Pharma
- 42971-09-5 / 80038-06-8 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Afton Pharma
- 42971-09-5 / 80038-06-8 Vinpocetine 98%
- Inquiry
- 2024-01-19
- Since:2022-03-18
- Address: Room 601, Unit 1, Building 1, 188 Xinhuali, North Xinhua Road, Xiangdu District, Xingtai city, Hebei